Genomic Medicine Sweden
Genomic Medicine Sweden, GMS, is paving the way for improved diagnostics, care and treatment.
News
GMS signs agreement with Swedish Life Science industry to strengthen collaboration in precision medicine
Genomic Medicine Sweden, GMS, has entered into an agreement with the Swedish Life Science sector's trade associations to promote industry collaboration. The aim is to jointly strengthen national conditions for precision medicine."For GMS, this agreement is a step...
The GMS560 gene panel guides cancer patients to personalised treatment and participation in clinical studies
Genomic Medicine Sweden (GMS) has developed a broad gene panel for solid tumours that facilitates detailed diagnostics for current and next generation targeted therapies. The new gene panel will be implemented in routine healthcare during the autumn.As precision...
Successful implementation of precision medicine at a national level
In Sweden, the key to the successful implementation of precision medicine in healthcare has been the bottom-up approach where academia and healthcare have joined forces to build a national infrastructure. 42 authors from the Clinical Genomics platform at SciLifeLab...
Sweden’s ambitious national collaboration for genomic medicine
Our strategic mission is to foster collaboration between healthcare providers, academia, patient organizations and industry and realize precision medicine by effectively utilizing the rapidly advancing sequencing technologies to provide the highest standards of genomic testing in routine clinical care throughout Sweden.
Healthcare
A close collaboration between healthcare and academia is central in introducing new forms of diagnostics as the basis for an individualized choice of treatment.
Patients & next of kin
Participation and knowledge from patients and next of kin representatives is crucial for GMS to be able to introduce precision medicine in health care based on the individual’s needs.
Industry
Through an active collaboration with industry, GMS will develop and provide tomorrow´s solutions for the diagnostics and treatment of various diseases.
Academia
GMS forms a strong basis for researchers to better understand why disease arises and how new forms of treatment can be developed.
JIM Symposium: Cutting-Edge Implementation of Precision Medicine in Europe
22-23 September, 2022 in Stockholm
This symposium focuses on how precision medicine will change and improve diagnostics, treatment and prevention, as well as the potential for research and innovation within the precision medicine framework.
Regional centers
Seven regional centers are the GMS engine
GMS is comprised of seven regional Genomic Medicine Centers (GMC). These joint centers act as the primary point of contact for sequencing patient samples within healthcare, thereby creating an integrated platform for both healthcare delivery and advanced medical research. Each GMC is a collaboration between a region with university hospital care, a university with a faculty of medicine, and SciLifeLab.
Participating partners
In collaboration with:
